© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 31, 2020
Investigators compared the 2010 and 2017 IDSA and SHEA guidelines to identify which better predicted C diff patients’ severity and mortality.
December 29, 2020
The first approved generic product for injection glucagon is also indicated for diagnostic use, when appropriate.
December 24, 2020
Screening for hepatitis B virus has become the norm in patients about to undergo anti-tumor-necrosis factor α therapy, but new research finds the risk of reactivation of resolved infections is low.
December 23, 2020
The investigators called their findings the “opposite of what was expected.”
December 22, 2020
The study authors wrote that understanding this phenomena can lead to determining the best therapeutic strategy with DAAs for certain patients.
The investigators measured a 3.5-month period before and after a policy was implemented to preserve hospital resources.
December 21, 2020
The TARGET-NASH study seeks to shed light on treatment for NASH and NAFLD.
Experts offered their advice on 2 domains, topic identification and ranking of priorities, for pediatric research realms.
December 18, 2020
Hepatitis B coinfection with COVID-19 did not increase either disease’s severity or increase duration of hospitalization, according to a small study in China.
December 17, 2020
Harvey Alter, Michael Houghton, and Charles Rice were awarded with the 2020 Nobel Prize in Physiology and Medicine.